M. Pesci

Infliximab prevents Crohn's disease recurrence after ileal resection.

M. Regueiro, A. Sepulveda, L. Baidoo, 2009, Gastroenterology.

Crohn's disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection

M. Regueiro, A. Sepulveda, L. Baidoo, 2011, Inflammatory bowel diseases.

[Nifurpipone in the chemotherapy of bacterial inflammation of the urinary ways in geriatrics].

M. Pesci, R. Bompani, G. Petronio, 1975, Minerva urologica.

How Did Italian Adolescents with Disability and Parents Deal with the COVID-19 Emergency?

S. Costi, F. Lombardi, S. Faccioli, 2021, International journal of environmental research and public health.

W1298 4.5 Yr Follow-up of Patients Enrolled in the Randomized Controlled Trial (RCT) of Infliximab (Inf) for Prevention of Postoperative Crohn's Disease (CD)

M. Regueiro, L. Baidoo, K. Kip, 2010 .

Postoperative Infliximab Is Not Associated with An Increase in Adverse Events in Crohn’s Disease

M. Regueiro, M. Schwartz, L. Baidoo, 2011, Digestive Diseases and Sciences.

T1207 Two Year Postoperative Follow-Up of Patients Enrolled in the Randomized Controlled Trial (RCT) of Infliximab (IFX) for Prevention of Recurrent Crohn's Disease (CD)

M. Regueiro, L. Baidoo, S. Plevy, 2009 .

M1225 Correlation of Histologic and Endoscopic Scores for Evaluation of Crohn's Disease Recurrence After Ileal Resection and Infliximab Therapy

M. Regueiro, A. Sepulveda, L. Baidoo, 2010 .

Long-Term Follow-up of Patients Enrolled in the Randomized Controlled Trial (RCT) of Infliximab (INF) for Prevention of Postoperative Crohnʼs Disease (CD): 1232

M. Regueiro, L. Baidoo, K. Kip, 2009 .